GENELUX CORPORATION Current Assets
GENELUX CORPORATION (GNLX) had Current Assets of $19.14 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $19.14M.
- 2026-03-31: Assets, Current $26.75M.
- 2025-12-31: Assets, Current $15.13M.
- 2025-09-30: Assets, Current $21.55M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $19.14M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $26.75M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $15.13M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $21.55M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $29.23M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $35.95M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $31.55M 10-K · filed 2026-03-19 |
| 2024-09-30 | $35.97M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $34.87M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $21.20M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $24.20M 10-K · filed 2025-03-28 |
| 2023-09-30 | $31.18M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $28.68M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $12.06M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.89M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |